Other mechanisms (e.g. loss of SMAD4 or of the tumor suppressor p15INK4B) could also be involved in the resistance to the anti-tumor effect of ActA, as it was shown in other types of cancer [26, 48]. This evidence concerns the gene ACTA1 and neoplasm.